Skip to main content

Serum-Free Media Market Revenue Growth, Demand, Share, Size Estimation and Opportunity Forecast by 2032

 Global serum-free media market has evolved to be an integrative aspect of healthcare procedures by providing most diagnostic laboratory tests equipped with infectious disease, oncology, and genetics. The massively parallel methods that have now transcended media-based cellular diagnostics further allow the sequencing of entire genomes at very low costs and are expected to grow further in the coming years due to the continuous increase in prognostic assessments for a wide range of diseases.

The global serum-free media market was valued at $1,022.4 million in 2021 and is expected to reach $3,920.5 million by 2032, registering a CAGR of 12.73% during the forecast period 2022-2032. The growth in the global serum-free media market is expected to be driven by factors such as the low risk of contamination in the media, rising awareness of media-based diagnostic testing, and significant number of funding for executing research and development.

Global Serum-Free Media Market

 

Recent Developments in the Global Serum-Free Media Market

•    In August 2022, Thermo Fisher Scientific Inc. expanded the cell culture media manufacturing facility in Grand Island, New York, to support the production of new vaccines and biologics. This expansion would support the worldwide media supply and increase the capacity to create high-quality technologies.
•    In May 2022, FUJIFILM Irvine Scientific completed its new bioprocessing innovation and collaboration center in China. The new center would enable local resources and expertise required to optimize cell culture media and workflows to aid the production of vaccines, advanced therapies, and biotherapeutic drug development in China.
•    In September 2021, Bio-Techne Corporation developed a new medium ExCellerate IpsC expansion medium, for IpsC research in regenerative medicine.
•    In April 2021, PromoCell GmbH launched an upgrade to its Keratinocyte Cell Culture Portfolio. The company expanded its improved animal-extract-free Keratinocyte Growth Medium 3 for the standardized isolation and development of juvenile and adult Normal Human Keratinocytes.
•    In March 2021, the company also launched its improved third-generation Melanocyte Cell Culture Portfolio. Melanocyte Growth Medium M3 is a serum-free, bovine pituitary extract (BPE)-free, and phorbol myristate acetate (PMA)-free media formulation.

Demand – Drivers and Limitations

Following are the demand drivers for the global serum-free media market:

•    Low Risk of Contamination as a Demand Driver
•    Launch of innovative products in Serum-Free Media Ecosystem
•    Low reception cost involving small and medium enterprises in comparison to animal derived media

The market is expected to face some limitations too due to the following challenges:

•    Slow Growth Rate in Comparison to Serum-Supplemented Media
•    Requirement of Diverse Cell-Type for Specific Media Formulation

Key Market Players and Competition Synopsis

The companies that are profiled have been selected based on inputs gathered from primary experts and analyzing company coverage, product portfolio, and market penetration.

Global Serum-Free Media Market

Some of the prominent names established in this market are:

Company Type 1: Serum-Free Media Private Industry
•    MP BIOMEDICALS. 
•    HiMedia Laboratories
•    RD Systems, Inc.
•    Sino Biological, Inc.
•    PAN-Biotech.
•    PromoCell GmbH
•    Athena Environmental Sciences, Inc.
•    STEMCELL Technologies Inc.

Company Type 2: Serum-Free Media Public Industry
•    Corning Incorporated
•    Lonza Group AG
•    Merck KgaA
•    Sartorius AG
•    Thermo Fisher Scientific Inc.
•    FUJIFILM Holdings Corporation
•    Danaher.

 

 

Key Questions Answered in Report

  • What is the role of media type in serum-free media, and what are the advantages associated with serum-free media? What is the importance of recombinant proteins in cell culture applications?
  • What are the key trends in the global serum-free media market? How is the market evolving, and what is its future scope?
  • What are the major drivers, challenges, and opportunities of the global serum-free media market?
  • What are the key developmental strategies implemented by the key players in the global serum-free media market to sustain the competition of the market? What is the percentage share of each of the key players in different key developmental strategies?
  • What is the regulatory scenario of the global serum-free media market? What are the initiatives implemented by different governmental bodies and guidelines put forward to regulate the commercialization of serum-free media products?

 

BIS Related Studies

Global Recombinant Cell Culture Supplements Market

Comments

Popular posts from this blog

Microbiome Therapeutics Market Growth, Segmentation, Opportunity and Forecast to 2032

  Global microbiome therapeutics market is expected to grow further in the coming years due to the continuous increase in awareness and need for better and safer treatment alternatives and the dominance of gastrointestinal (GI) and infectious diseases segment can be attributed to the existing dominance of microbiome therapeutics available for a variety of indications ranging from diarrhea and gut dysbiosis to skin disorders, cancer indications among others. The global microbiome therapeutics market which accounted for $306.3 million in 2021 is expected to reach $3,204 million by 2032, reporting a CAGR of 24.95% during the forecast period 2022-2032. The existing   microbiome therapeutics market    is favored by multiple factors, including the rising geriatric populations coupled with the increasing adoption of inorganic growth strategies by key players in the market. Impact of COVID-19 There were numerous consequences due to the COVID-19 pandemic, especially...

Ligase Market Opportunities, Strategies, Share, Segmentation, In-depth Analysis 2032

  The global ligase market is progressing rapidly with a significant increase in the research and development activities pertaining to a wide range of ligase product for disease detection, accentuating their criticality in healthcare. Ligase enzyme has a critical role in the molecular diagnostics approach, as it ensures the safe and effective application of targeted therapeutics. Most of the players in the global ligase market offer products encompassing the ligation kits and enzymes. The global  ligase market  is projected to reach $651.4 million by 2032 from $371.2 million in 2021, at a CAGR of 5.29% during the forecast period 2022-2032. The growth in the global ligase market is expected to be driven by factors such as the increasing prevalence of infectious and genetic diseases on a global level, rising awareness of enzyme based diagnostic testing and significant number of funding for executing research and development.   Impact Several techniques are employed in ...

Digital PCR Market size,Share, Leading Players, Growth, Development and Demand Forecast to 2032

  Increasing investments in R&D for d-PCR molecular diagnostics is one of the major opportunities in the global digital PCR market. Several biotechnology and life sciences companies are working collaboratively on diagnostic test development and using d-PCR as a therapeutic means for applications in several disease indications to enable efficient diagnosis, treatment selection, and treatment monitoring. The global  digital PCR market   is projected to reach $2,847.8 million by 2032 from $441.2 million in 2021, at a CAGR of 18.73% during the forecast period 2022–2032. The growth in the global digital PCR market is expected to be driven by factors such as the increasing prevalence of infectious and genetic diseases globally, the rising awareness of d-PCR-based diagnostic testing, and the significant number of funding for executing research and development. Impact of COVID-19 The current global digital PCR market comprises kits and assays, system, and reagents and consuma...